Changes in cellular immune activation and memory T-cell subsets in HIV-infected Zambian children receiving HAART

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 5, 2014, Pages 455-462

  Rainwater Lovett, Kaitlin ^a,e   Nkamba, Hope ^b   Mubiana Mbewe, Mwangelwa ^c   Moore, Carolyn B ^c,d,f   Margolick, Joseph ^a   Moss, William J ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

^c Primary Care and Health Systems Department   (Zambia)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Children; HIV; Immune reconstitution; T cells

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; INTERLEUKIN 7 RECEPTOR ALPHA;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR IMMUNITY; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; INFANT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; HIV INFECTIONS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LONGITUDINAL STUDY; ZAMBIA;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; INFANT; LONGITUDINAL STUDIES; MALE; T-LYMPHOCYTE SUBSETS; ZAMBIA;

EID: 84925555007     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000342     Document Type: Conference Paper

References (42)

1. UNAIDS. Report on the global AIDS epidemic 2010. 2011. Available at: http://www.unaids.org/globalreport/Global-report.htm. Accessed August 29, 2011.
2. Prendergast A, O'Callaghan M, Menson E, et al. Factors influencing T cell activation and programmed death 1 expression in HIV-infected children. AIDS Res Hum Retroviruses. 2012;28:465-468.
3. Puissant-Lubrano B, Combadiere B, Duffy D, et al. Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients. Vaccine. 2009;27:3576-3583.
4. Elrefaei M, McElroy MD, Preas CP, et al. Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol. 2004;173:2184-2189.
5. Rainwater-Lovett K, Moss WJ. Immunologic basis for revaccination of HIV-infected children receiving HAART. Future Virol. 2011;6:59-71.
6. Ssewanyana I, Baker CA, Ruel T, et al. The distribution and immune profile of T cell subsets in HIV-infected children from Uganda. AIDS Res Hum Retroviruses. 2009;25:65-71.
7. Rainwater-Lovett K, Nkamba H, Mubiana-Mbewe M, et al. Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children. J Acquir Immune Defic Syndr. 2013;65:505-509.
8. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
9. Michie CA, McLean A, Alcock C, et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 1992;360:264-265.
10. Sallusto F, Lenig D, Forster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708-712.
11. Ono E, Nunes dos Santos AM, de Menezes Succi RC, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res. 2008;41:700-708.
12. Resino S, Navarro J, Bellon JM, et al. Naive and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol. 2001;125:266-273.
13. Ruel T, Ssewanyana I, Achan J, et al. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clin Immunol. 2009;131:410-414.
14. Ssewanyana I, Elrefaei M, Dorsey G, et al. Profile of T cell immune responses in HIV-infected children from Uganda. J Infect Dis. 2007;196: 1667-1670.
15. Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, et al. Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities. J Infect Dis. 2013;208:1747-1755.
16. Liu Z, Cumberland WG, Hultin LE, et al. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:83-92.
17. Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4:1191-1198.
18. van Leeuwen EM, de Bree GJ, Remmerswaal EB, et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood. 2005;106:2091-2098.
19. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control. 1974;19:716-723.
20. R Core Team. R: a language and environment for statistical computing. 2014. Available at: http://www.R-project.org/. Accessed September 19, 2013.
21. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9:811-818.
22. Mazo IB, Honczarenko M, Leung H, et al. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity. 2005;22:259-270.
23. Kaufmann GR, Zaunders J, Murray J, et al. Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling. AIDS Res Hum Retroviruses. 2001; 17:147-159.
24. Wherry EJ, Blattman JN, Murali-Krishna K, et al. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77:4911-4927.
25. Rainwater-Lovett K, Nkamba HC, Mubiana-Mbewe M, et al. Immunologic risk factors for early mortality after starting antiretroviral therapy in HIV-infected Zambian children. AIDS Res Hum Retroviruses. 2013;29: 479-487.
26. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443:350-354.
27. Eisele E, Siliciano RF. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity. 2012;37:377-388.
28. Katlama C, Deeks SG, Autran B, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet. 2013;381:2109-2117.
29. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15:893-900.
30. Weninger W, Crowley MA, Manjunath N, et al. Migratory properties of naive, effector, and memory CD8(+) T cells. J ExpMed. 2001;194:953-966.
31. Scott-Algara D, Rouzioux C, Blanche S, et al. In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations. J Acquir Immune Defic Syndr. 2010;53:553-563.
32. Gibb DM, Newberry A, Klein N, et al. Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. Lancet. 2000;355:1331-1332.
33. Resino S, Seoane E, Perez A, et al. Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy. BMC Infect Dis. 2006;6:112.
34. Resino S, Galan I, Bellon JM, et al. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. J Clin Immunol. 2003;23:279-289.
35. Hainaut M, Ducarme M, Schandene L, et al. Age-related immune reconstitution during highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J. 2003;22: 62-69.
36. Jordan KA, Furlan SN, Gonzalez VD, et al. CD8 T cell effector maturation in HIV-1-infected children. Virology. 2006;347:117-126.
37. Navarro J, Resino S, Bellon JM, et al. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2001;17:525-532.
38. Weinberg A, Dickover R, Britto P, et al. Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS. 2008;22:2267-2277.
39. Guihot A, Tubiana R, Breton G, et al. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy. AIDS. 2010;24:614-617.
40. Sagnia B, Ateba NF, Ndiang Moyo TS, et al. Reference values of lymphocyte subsets in healthy, HIV-negative children in Cameroon. Clin Vaccin Immunol. 2011;18:790-795.
41. Masopust D, Vezys V, Marzo AL, et al. Preferential localization of effector memory cells in nonlymphoid tissue. Science. 2001;291: 2413-2417.
42. Macallan DC, Wallace D, Zhang Y, et al. Rapid turnover of effector-memory CD4(+) T cells in healthy humans. J ExpMed. 2004;200:255-260.